Healthcare Databases for Drug Safety Research: Data Validity Assessment Remains Crucial

Overview

Journal Drug Saf

Specialties Pharmacology
Toxicology

Date 2018 May 2

PMID 29714003

Citations 3

Authors

Nigel S B Rawson

Carl DArcy

Affiliations

Soon will be listed here.

Abstract

Administrative healthcare utilization databases are frequently used either individually or as a component of aggregated data for evaluating drug safety issues without taking into account their known deficiencies. All too often insufficient evidence is provided about their validity for the purposes for which they are used. The assessment of data validity is a key constituent that should be included in drug safety research studies and should take a broad multifaceted approach that encompasses both diagnostic and drug exposure data. Drug safety researchers need to continue advancing their knowledge of the data resources they use and to ensure that they and the users of their research understand the limitations of the data that are the foundation on which their research is built. Fundamental issues regarding data validity should be addressed in each use of administrative data for drug safety research.

Citing Articles

Where are the data linking infant outcomes, breastfeeding and medicine exposure? A systematic scoping review.

Jordan S, Komninou S, Lopez Leon S PLoS One. 2023; 18(4):e0284128.

PMID: 37099508 PMC: 10132552. DOI: 10.1371/journal.pone.0284128.

Breastfeeding, pregnancy, medicines, neurodevelopment, and population databases: the information desert.

Jordan S, Bromley R, Damase-Michel C, Given J, Komninou S, Loane M Int Breastfeed J. 2022; 17(1):55.

PMID: 35915474 PMC: 9343220. DOI: 10.1186/s13006-022-00494-5.

Observational research on sodium glucose co-transporter-2 inhibitors: A real breakthrough?.

Raschi E, Poluzzi E, Fadini G, Marchesini G, De Ponti F Diabetes Obes Metab. 2018; 20(12):2711-2723.

PMID: 30003655 PMC: 6283243. DOI: 10.1111/dom.13468.

References

Rawson N, Robson D . Concordance on the recording of cancer in the Saskatchewan Cancer Agency Registry, hospital charts and death registrations. Can J Public Health. 2000; 91(5):390-3. PMC: 6979827. View

Koro C, Fu Q, Stender M . An assessment of the effect of thiazolidinedione exposure on the risk of myocardial infarction in type 2 diabetic patients. Pharmacoepidemiol Drug Saf. 2008; 17(10):989-96. DOI: 10.1002/pds.1640. View

Moore T, Furberg C . Electronic Health Data for Postmarket Surveillance: A Vision Not Realized. Drug Saf. 2015; 38(7):601-10. DOI: 10.1007/s40264-015-0305-9. View

DArcy C, Ham M, Goldie S . The development of a comprehensive psychiatric service utilization research data file. Can J Public Health. 1976; 67(3):237-48. View

Rawson N, Malcolm E, DArcy C . Reliability of the recording of schizophrenia and depressive disorder in the Saskatchewan health care datafiles. Soc Psychiatry Psychiatr Epidemiol. 1997; 32(4):191-9. DOI: 10.1007/BF00788238. View

Tricco A, Pham B, Rawson N . Manitoba and Saskatchewan administrative health care utilization databases are used differently to answer epidemiologic research questions. J Clin Epidemiol. 2008; 61(2):192-197. DOI: 10.1016/j.jclinepi.2007.03.009. View

Guess H, West R, Strand L, Helston D, Lydick E, Bergman U . Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of nonsteroidal anti-inflammatory drugs in Saskatchewan, Canada 1983. J Clin Epidemiol. 1988; 41(1):35-45. DOI: 10.1016/0895-4356(88)90007-8. View

Rawson N, Malcolm E . Validity of the recording of ischaemic heart disease and chronic obstructive pulmonary disease in the Saskatchewan health care datafiles. Stat Med. 1995; 14(24):2627-43. DOI: 10.1002/sim.4780142404. View

Edouard L, Rawson N . Reliability of the recording of hysterectomy in the Saskatchewan health care system. Br J Obstet Gynaecol. 1996; 103(9):891-7. DOI: 10.1111/j.1471-0528.1996.tb09908.x. View

10.

Juurlink D, Gomes T, Lipscombe L, Austin P, Hux J, Mamdani M . Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study. BMJ. 2009; 339:b2942. PMC: 2728804. DOI: 10.1136/bmj.b2942. View

11.

Tzoulaki I, Molokhia M, Curcin V, Little M, Millett C, Ng A . Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database. BMJ. 2009; 339:b4731. PMC: 2788912. DOI: 10.1136/bmj.b4731. View

12.

Stockl K, Le L, Zhang S, Harada A . Risk of acute myocardial infarction in patients treated with thiazolidinediones or other antidiabetic medications. Pharmacoepidemiol Drug Saf. 2008; 18(2):166-74. DOI: 10.1002/pds.1700. View

13.

Tomlin A, Reith D, Woods D, Lloyd H, Smith A, Fountain J . A Pharmacoepidemiology Database System for Monitoring Risk Due to the Use of Medicines by New Zealand Primary Care Patients. Drug Saf. 2017; 40(12):1259-1277. DOI: 10.1007/s40264-017-0579-1. View

14.

Rawson N, Rawson M . Acute adverse event signalling scheme using the Saskatchewan Administrative health care utilization datafiles: results for two benzodiazepines. Can J Clin Pharmacol. 1999; 6(3):159-66. View

15.

Brownstein J, Murphy S, Goldfine A, Grant R, Sordo M, Gainer V . Rapid identification of myocardial infarction risk associated with diabetes medications using electronic medical records. Diabetes Care. 2009; 33(3):526-31. PMC: 2827502. DOI: 10.2337/dc09-1506. View

16.

Rawson N, DArcy C . Assessing the validity of diagnostic information in administrative health care utilization data: experience in Saskatchewan. Pharmacoepidemiol Drug Saf. 2004; 7(6):389-98. DOI: 10.1002/(SICI)1099-1557(199811/12)7:6<389::AID-PDS380>3.0.CO;2-S. View

17.

Psaty B, Boineau R, Kuller L, Luepker R . The potential costs of upcoding for heart failure in the United States. Am J Cardiol. 1999; 84(1):108-9, A9. DOI: 10.1016/s0002-9149(99)00205-2. View

18.

Filion K, Chateau D, Targownik L, Gershon A, Durand M, Tamim H . Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis. Gut. 2013; 63(4):552-8. PMC: 3963530. DOI: 10.1136/gutjnl-2013-304738. View

19.

Dormuth C, MacLure M, Carney G, Schneeweiss S, Bassett K, Wright J . Rosiglitazone and myocardial infarction in patients previously prescribed metformin. PLoS One. 2009; 4(6):e6080. PMC: 2698985. DOI: 10.1371/journal.pone.0006080. View

20.

Vanasse A, Carpentier A, Courteau J, Asghari S . Stroke and cardiovascular morbidity and mortality associated with rosiglitazone use in elderly diabetic patients. Diab Vasc Dis Res. 2010; 6(2):87-93. DOI: 10.1177/1479164109336047. View